Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check2 days agoChange DetectedFooter updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedPage shows a revision reference updated from v3.3.1 to v3.3.2; there are no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1. No substantive study information or interactive elements appear to be affected.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding lapse notice on the page; it was an administrative banner unrelated to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe screenshots show only minor layout and formatting adjustments on the study page, with no change to the core study content such as the study purpose, eligibility criteria, endpoints, or listed locations. No new data or changes to the DAPAgliflozin (DAPACARD) study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.